Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review voucher
Pharma
Novartis complies with FDA 'flexibility' ask in Pluvicto filing
Novartis didn't use a priority review voucher for Pluvicto's new application upon a request from the FDA, CEO Vas Narasimhan explained.
Angus Liu
Oct 29, 2024 10:51am
Biogen retains biosimilars as Leqembi plows ahead
Aug 1, 2024 10:15am
FDA blesses Pfizer with priority review voucher for Paxlovid nod
May 24, 2024 2:04pm
FDA signs off on Valneva's chikungunya vaccine Ixchiq
Nov 10, 2023 9:55am
Krystal's topical gene therapy Vyjuvek gains steam: analyst
Nov 6, 2023 3:14pm
Subcutaneous Vyvgart helps Argenx treat a 'broader population'
Nov 1, 2023 9:35am
